In a Time of Universal Deceit, Telling the Truth is Revolutionary.
Thursday, September 29, 2022
Menu
Senate panel backs 12-year biotech drug shelter
WASHINGTON (Reuters) - Biotechnology medicines would be protected from cheaper rivals for 12 years under a plan that cleared a U.S. Senate committee on Monday.
WASHINGTON (Reuters) – Biotechnology medicines would be protected from cheaper rivals for 12 years under a plan that cleared a U.S. Senate committee on Monday.
